TY - JOUR
T1 - Antiestrogen therapy for breast cancer
T2 - current strategies and potential causes for therapeutic failure.
AU - Iino, Y.
AU - Gibson, D. F.
AU - Jordan, V. C.
N1 - Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine
PY - 1991
Y1 - 1991
N2 - There is an enormous literature that supports the use of tamoxifen as the treatment of choice for breast cancer. However, preliminary evidence suggests that long-term treatment with tamoxifen may expose the women to an increased risk of liver and endometrial cancer. This is probably only of concern to young women with stage I (node negative) disease. It remains to be seen whether any of the new strategies, including the new antiestrogens discussed here and novel endocrine therapies, will prove any better as an antitumor treatment. Treatments will probably be directed initially at treating patients after tamoxifen failure and ultimately at treating hormone-independent cancers. These therapies may involve the autocrine growth factors produced by breast cancer cells as potential targets. Such development of novel treatments will be extremely beneficial to these women, who face a worrying lack of therapeutic opportunities, with the exception of chemotherapy.
AB - There is an enormous literature that supports the use of tamoxifen as the treatment of choice for breast cancer. However, preliminary evidence suggests that long-term treatment with tamoxifen may expose the women to an increased risk of liver and endometrial cancer. This is probably only of concern to young women with stage I (node negative) disease. It remains to be seen whether any of the new strategies, including the new antiestrogens discussed here and novel endocrine therapies, will prove any better as an antitumor treatment. Treatments will probably be directed initially at treating patients after tamoxifen failure and ultimately at treating hormone-independent cancers. These therapies may involve the autocrine growth factors produced by breast cancer cells as potential targets. Such development of novel treatments will be extremely beneficial to these women, who face a worrying lack of therapeutic opportunities, with the exception of chemotherapy.
UR - http://www.scopus.com/inward/record.url?scp=0025984019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025984019&partnerID=8YFLogxK
U2 - 10.1007/978-1-4615-3940-7_10
DO - 10.1007/978-1-4615-3940-7_10
M3 - Review article
C2 - 1672078
AN - SCOPUS:0025984019
SN - 0927-3042
VL - 53
SP - 221
EP - 237
JO - Cancer treatment and research
JF - Cancer treatment and research
ER -